W43 (Rosiglitazone Maleate 8 mg (base))
Pill with imprint W43 is Red, Elliptical / Oval and has been identified as Rosiglitazone Maleate 8 mg (base). It is supplied by West-ward Pharmaceutical Corp..
Rosiglitazone is used in the treatment of diabetes, type 2 and belongs to the drug class thiazolidinediones. Risk cannot be ruled out during pregnancy. Rosiglitazone 8 mg (base) is not a controlled substance under the Controlled Substances Act (CSA).
Images for W43
Rosiglitazone Maleate
- Imprint
- W43
- Strength
- 8 mg (base)
- Color
- Red
- Shape
- Elliptical / Oval
- Availability
- Prescription only
- Drug Class
- Thiazolidinediones
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- West-ward Pharmaceutical Corp.
- National Drug Code (NDC)
- 00143-9975
Related Images for "W43"
More about rosiglitazone
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Imprints, Shape & Color Data
- Drug Interactions
- En Español
- 8 Reviews
- Drug class: thiazolidinediones
- FDA Alerts (9)
Consumer resources
Other brands: Avandia
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
